ReviewFuture oncology (London, England)2025

Trastuzumab deruxtecan in the treatment of HER2-positive gastric cancer: a comprehensive review.

Amane Jubashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.